Espiridion Mendez, DO
General Practice · Wylie, TXNPI 1013103209
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,760 of the $22,809 with a category attached, or 99.8%. 5 manufacturers reported payments, led by Kedplasma LLC at 50.4% of the total. 2023 is the largest year on record at $19,260, more than ten times the $23 reported in 2020. Among general practice clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $877.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kedplasma LLC$12K
- Takeda Pharmaceuticals U.S.A., Inc.$11K
- Merck$23
- Abbott$14
- Currax Pharmaceuticals LLC$12
What the payments were for
- Consulting fees$22,760100%
- Food & beverage$490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kedplasma LLC | 18 | $11,500 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $11,260 |
| Merck | 1 | $23 |
| Abbott | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $12 |
How this compares
$22,809 in reported general payments places this provider in the 95th percentile of 8,074 general practice providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $333 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $269 |
| Ondansetron OdtOndansetron | 28 | $256 |
| Clindamycin Hcl | 22 | $252 |
| Cephalexin | 48 | $247 |
| Doxycycline Monohydrate | 15 | $198 |
| Ciprofloxacin Hcl | 29 | $197 |
| Cyclobenzaprine Hcl | 58 | $168 |
| Ketorolac Tromethamine | 14 | $166 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $120 |
| Prednisone | 49 | $118 |
| Azithromycin | 34 | $117 |
| Naproxen | 32 | $107 |
| Furosemide | 13 | $78 |
Paid to pharmacies, not to this prescriber.
Other general practice in Wylie
- Marcus LastimadoFort Bliss$2.3M
- Christina DeanFrisco$1.9M
- Paul ShrodeMissouri City$1.2M
- Alan DouglasSan Antonio$609K
- C Mike MeekAustin$509K
- Young KwonDallas$288K
- Matthew HicksFriendswood$268K
- Kathleen Szelei-StevensHouston$253K
- Hoa TranPearland$156K
- Mitchell KimRichardson$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.